Drawing for ONCOBETA

USPTO serial 90527069

ONCOBETA

Reviewed by CopyMark Law Group

Reg. 7787489Status 700Registered
Filing date
Status date
Registration date
May 6, 2025
Examiner
LEE, OLIVIA SUNMIN
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with ONCOBETA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Daniel P. Mullarkey

Daniel P. Mullarkey Polsinelli PCPO BOX 140310Kansas City, MO 64114-0310United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for medical purposes, namely, for use in chemotherapy; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical preparations for medical purposes, namely, for use in chemotherapy; radiopharmaceutical preparations for the treatment of cancer, namely, 188-Rhenium containing preparations in the nature of sodium Re-188-perrhenate; radiopharmaceutical preparations for use in nuclear medicine; pharmaceutical preparations for use in brachytherapy and epidermal radionuclide treatment; radiopharmaceutical preparations for the treatment of skin cancer and skin lesions; radiopharmaceutical preparations for the use in cosmetic dermatology proceduresACTIVEDec 1, 2024
040Preparing personalized radiopharmaceutical preparations for the treatment of cancer or cosmetic uses, namely, custom manufacture of 188-Rhenium containing preparations in the nature of sodium Re-188-perrhenate by a pharmaceutical compounderACTIVEDec 1, 2024
044Medical imaging services, particularly services in the field of radiologic and nuclear medicine; radiation therapy for the treatment of cancer, in particular skin cancer and for cosmetic use; preparing personalized radiopharmaceutical preparations for the treatment of cancer or cosmetic uses, namely, pharmaceutical compounding of 188-Rhenium containing preparations in the nature of sodium Re-188-perrhenateACTIVEDec 1, 2024

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jun 25, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 25, 2026ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jun 25, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 25, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jun 25, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jun 25, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
May 6, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
May 6, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 17, 2025SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Apr 17, 2025CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 7, 2025SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 7, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jan 6, 2025IUAFUSE AMENDMENT FILED—
Jan 6, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jan 6, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 6, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 30, 2024EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 18, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 18, 2024EX4GSOU EXTENSION 4 GRANTED—
Jun 18, 2024EXT4SOU EXTENSION 4 FILED—
Jun 18, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 26, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 22, 2023EX3GSOU EXTENSION 3 GRANTED—
Dec 22, 2023EXT3SOU EXTENSION 3 FILED—
Dec 22, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 27, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 25, 2023EX2GSOU EXTENSION 2 GRANTED—
Jun 25, 2023EXT2SOU EXTENSION 2 FILED—
Jun 25, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 8, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 6, 2022EX1GSOU EXTENSION 1 GRANTED—
Dec 6, 2022EXT1SOU EXTENSION 1 FILED—
Dec 6, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 28, 2022NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
May 19, 2022ETOPEXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED—
May 17, 2022DOCKASSIGNED TO EXAMINER—
Dec 6, 2021ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Nov 9, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 9, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 20, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 1, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 17, 2021XAECEXAMINER'S AMENDMENT ENTERED—
Sep 17, 2021GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 17, 2021GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 17, 2021CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 9, 2021DOCKASSIGNED TO EXAMINER—
May 17, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 16, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance